Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thrombosis × apixaban × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 4 Neoplasms 2 Thrombosis 1 Thrombocythemia, Essential 1 Pulmonary Embolism 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Myeloproliferative Disorders 1 Multiple Myeloma 1

Interventions

Dalteparin 2 apixaban 1 Warfarin 1 Tinzaparin 1 Heparin, Low-Molecular-Weight 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00320255 2016-08-16

A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Bristol-Myers Squibb

Phase 2 Completed

130 enrolled 22 charts

Neoplasms, Pulmonary Embolism, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡